Furthermore, TLR-4 was found to be overexpressed in gliomas and correlated with increased cellular proliferation, while glioma U251 cell lines treated with the TLR-4 lipopolysaccharide (LPS) ligand had enhanced tumor growth and decreased survival [26]. The gene discussed is TLR4; the disease is central nervous system cancer.